Salvatore Massimo Petrina – Smart D-Dimer Use: A 3-Step Pathway to Better Diagnosis
Salvatore Massimo Petrina, Hospital Physician Cardiology ASP Ragusa, shared on LinkedIn:
“Smart D-Dimer Use: A 3-Step Pathway to Better Diagnosis
Navigating D-dimer results can be tricky. Its high sensitivity but low specificity means it’s a powerful tool if used correctly. Overuse can lead to unnecessary anxiety and imaging, while underuse can miss critical diagnoses like PE or DVT.
Based on the clinician’s guide, here’s a simple 3-step pathway to optimize D-dimer use in your practice:
Step 1: Assess Pre-Test Probability (PTP)
Never order a D-dimer in a vacuum. Start by assessing the clinical likelihood of Venous Thromboembolism (VTE) using a validated risk score (e.g., Wells’ score). This is the most critical step.
Step 2: D-Dimer for Low/Medium PTP
If the PTP is low or intermediate, a D-dimer test is appropriate. A negative result can effectively rule out VTE, avoiding the need for further imaging.
Step 3: Imaging for High PTP
If the PTP is high, proceed directly to diagnostic imaging (e.g., CT pulmonary angiography). A D-dimer test in this scenario is often a detour that delays definitive treatment.
Optimizing Specificity and Avoiding Pitfalls:
Beware of False Positives: Remember that factors like pregnancy, malignancy, Aortic dissection and inflammation can elevate D-dimer levels.
Use Age-Adjusted Cutoffs: For patients over 50, use an age-adjusted cutoff (Age x 10 ng/mL) to improve specificity and reduce false positives.
Consider Clinical Algorithms: Tools like the PERC and YEARS rules can further streamline decision-making in the emergency department.
Using a structured approach ensures we leverage the D-dimer’s strengths while minimizing its weaknesses, leading to better patient outcomes.”

Explore more posts for deeper insights into hemostasis with Hemostasis Today.
-
Jul 19, 2026, 16:59Rupam Manna: Not All Portal Vein Involvement in HCC Is the Same
-
Jul 19, 2026, 16:58Axel Cangas: Exploring the Future of Hemophilia Care at ISTH 2026
-
Jul 19, 2026, 16:58Aviva Schwartz: Air Pollution and Women’s Hematological Health in the Spotlight at ISTH 2026
-
Jul 19, 2026, 16:56Lola Sepot-Boucherit: Reimagining the Future of Rare Bleeding Disorders at ISTH 2026
-
Jul 19, 2026, 16:54Belén de la Morena Barrio: Presenting Our Research on Long-Read Sequencing for Genetic Diagnosis at ISTH 2026
-
Jul 19, 2026, 16:52Shamee Shastry: Sometimes the Answer is Not in the Test Tube Alone, but at the Patient’s Bedside
-
Jul 19, 2026, 16:52Manuela Albisetti: Congratulations to Alessandra Bosch on an Outstanding ISTH 2026 Talk
-
Jul 19, 2026, 16:44Fernanda Orsi: A Memorable Week of Science and Collaboration at ISTH 2026
-
Jul 19, 2026, 16:37William Aird: A Visual Guide to Understanding von Willebrand Disease